Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases

E-ISSN： 2212-3954|5|3|195-202

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.5, Iss.3, 2010-11, pp. : 195-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

Neural stem cells: therapeutic potential for neurodegenerative diseases

By Gincberg Galit Arien-Zakay Hadar Lazarovici Philip Lelkes Peter I.

British Medical Bulletin, Vol. 104, Iss. 1, 2012-12 ,pp. : 7-19

Oxford University Press

Access to resources Recommend Favorite

Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 3, 2012-01 ,pp. : 218-229

Bentham Science Publishers

Access to resources Recommend Favorite

Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 22, 2015-11 ,pp. : 5239-5250

John Wiley & Sons Inc

Access to resources Recommend Favorite